Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 1—January 2025
Online Report

Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022

Jiyan Ma, Yang Yang, and Yangmu HuangComments to Author 
Author affiliation: Author affiliation: Peking University School of Public Health, Beijing, China

Main Article

Figure 4

Distribution of NSFC projects and R&D pipeline by disease in study of R&D of medical countermeasures for emerging infectious diseases, China, 1990–2022. The figure shows a rough comparison between basic and applied research because NSFC projects were collected during 1990–2019 and the R&D pipeline was updated in September 2022. A) Diseases with crucial gaps in basic research indicated by lack of NSFC projects. B) Diseases with crucial gaps in applied research indicated by lack of R&D pipeline. C) Disease that might enhance translational research from basic to application include those with a large discrepancy between the number of NSFC projects and R&D pipeline (in descending order). MERS-CoV, Middle East respiratory syndrome coronavirus; NSFC, National Natural Science Foundation of China; R&D, research and development.

Figure 4. Distribution of NSFC projects and R&D pipeline by disease in study of R&D of medical countermeasures for emerging infectious diseases, China, 1990–2022. The figure shows a rough comparison between basic and applied research because NSFC projects were collected during 1990–2019 and the R&D pipeline was updated in September 2022. A) Diseases with crucial gaps in basic research indicated by lack of NSFC projects. B) Diseases with crucial gaps in applied research indicated by lack of R&D pipeline. C) Disease that might enhance translational research from basic to application include those with a large discrepancy between the number of NSFC projects and R&D pipeline (in descending order). MERS-CoV, Middle East respiratory syndrome coronavirus; NSFC, National Natural Science Foundation of China; R&D, research and development.

Main Article

Page created: November 15, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external